Abstract
It was found that ginsenoside Rg1 exerts anti-eczema effects in a mouse model without overt toxicity. I was further found that the compound inhibits M2 macrophage polarization, in which AMPKα inactivation is involved, in mouse lesional skin and in cultured cells. These novel findings indicate that ginsenoside Rg1 can be developed into an effective and safe anti-eczema agent. This study was supported by Laboratory JaneClare Limited.
| Original language | English |
|---|---|
| Publication status | Published - 16 Aug 2024 |
| Event | International Conference of the Modernization of Chinese Medicine & Health Products 2024 - Hong Kong Convention and Exhibition Centre, Hong Kong, Hong Kong, China Duration: 15 Aug 2024 → 16 Aug 2024 https://icmcm.hktdc.com/pdf/2024/Conference_eBooklet/e-booklet.pdf (Conference e-booklet) |
Conference
| Conference | International Conference of the Modernization of Chinese Medicine & Health Products 2024 |
|---|---|
| Abbreviated title | ICMCM 2024 |
| Country/Territory | Hong Kong, China |
| City | Hong Kong |
| Period | 15/08/24 → 16/08/24 |
| Internet address |
|
